J&J Vision targets presbyopia and astigmatism market with Acuvue MAX

Daily disposable lens launched for simultaneous correction of presbyopia and astigmatism

1.00 D cylinder design supports correction of up to 1.75 D of astigmatism

ACUVUE® OASYS MAX 1-Day Multifocal for Astigmatism

Johnson & Johnson Vision Korea is expanding its multifocal contact lens portfolio with the launch of a new daily disposable lens designed to correct both presbyopia and astigmatism.

The company said on the 30th that it has launched Acuvue Oasys MAX 1-Day Multifocal for Astigmatism, a daily disposable contact lens capable of correcting both conditions.

The new product is aimed at consumers who experience presbyopia and astigmatism simultaneously. According to the company, it is the only daily disposable contact lens available in Korea that corrects both conditions.

Presbyopia generally becomes more pronounced after the age of 40, and around 1 in 2 people with presbyopia are also known to have astigmatism. When astigmatism is present, patients may experience discomfort with both near and distance vision. Until now, however, options addressing both conditions have been limited in Korea’s daily disposable contact lens market.

Acuvue Oasys MAX 1-Day Multifocal for Astigmatism incorporates Acuvue’s optical and material technologies into a single lens. It uses a 1.00 D cylinder design and is engineered to correct up to 1.75D of astigmatism. The product is intended to provide stable vision from near to far even as the degree of astigmatism increases.

Four core technologies are incorporated into the lens: Accelerated Stabilization Design, TearStable Technology, OptiBlue Light Filter, and 183 Pupil-Optimized Designs.

The Accelerated Stabilization Design uses four stabilization zones to reduce lens rotation and support the stable vision required for astigmatism correction. TearStable Technology is designed to improve wearing comfort by evenly distributing the wetting agent polyvinylpyrrolidone across both the front and back surfaces of the lens. The technology uses an enhanced PVP distribution method based on a dual-sided light-curing process.

OptiBlue technology is intended to provide clearer vision by filtering blue-violet light and reducing light scatter. The 183 Pupil-Optimized Designs take into account variations in pupil size according to age and refractive power, supporting a more natural visual experience across different distances.

With the launch, Johnson & Johnson Vision Korea has strengthened its Acuvue Oasys MAX 1-Day portfolio in the domestic market. The company expects eye care professionals, including opticians and ophthalmologists, to be able to recommend a wider range of products tailored to consumers’ vision correction needs.

Korea’s multifocal contact lens market is growing amid population aging and an increase in active older consumers. As more people seek to maintain active lifestyles involving travel, sports and cultural activities, interest is also increasing in visual quality and wearing convenience among presbyopia correction products.

Johnson & Johnson Vision Korea will also continue working with brand ambassador and golf coach Seri Park as part of the launch. The company plans to expand consumer engagement with the Acuvue multifocal brand through digital campaigns, trial programs and professional education.

Elizabeth Jung Lee, Country Manager of Johnson & Johnson Vision Korea, said, “Presbyopia cannot be defined as a single condition because it presents with a combination of symptoms, and many consumers experience both presbyopia and astigmatism.”

She added, “Acuvue Oasys MAX 1-Day Multifocal for Astigmatism was designed to correct these two major vision problems simultaneously. It will help eye care professionals provide more personalized vision correction solutions and allow consumers to maintain the lifestyles they want regardless of age.”